The Effect of Therapeutic Play Applied by Using Toy Nebulizer and Toy Mask on Child's Fear and Anxiety Level
NCT ID: NCT05415566
Last Updated: 2022-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2021-02-08
2022-06-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is the hypothesis of the study that the therapeutic play applied by using a toy mask and a toy nebulizer before inhaler treatment in children will reduce the child's fear and anxiety.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Distraction Methods Used During Inhalation Therapy on Children's Fear and Anxiety
NCT06510166
The Effect of Toy-Type Nebulizer on Fear and Anxiety in Children Receiving Inhaler Treatment
NCT05213013
The Effects Of Toy In Chıldren Durıng Inhaler Therapy
NCT06924528
The Effect of Playing With a Toy Nebulizer and Watching Cartoons on the Fear and Anxiety on Children
NCT06339112
Effect of Cartoon and Storytelling on the Children's Fear and Anxiety Levels During Inhalation Therapy With Nebulizer in Emergency Department
NCT07029633
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Reducing the fear and anxiety seen in children due to the hospital environment and illness is important in terms of children's acceptance of the treatment process. One of the methods used for this purpose is therapeutic play. Pediatric nurses should fulfill their nursing roles and responsibilities by including therapeutic play in their care processes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Routine Treatment Group
Inhaler treatment was applied according to the routine procedure in the emergency department.
No interventions assigned to this group
Therapeutic Play Group
Inhaler treatment was applied according to the "Therapeutic Play Guide" prepared by the researcher.
toy nebulizer and toy mask
The treatment was administered using therapeutic play.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
toy nebulizer and toy mask
The treatment was administered using therapeutic play.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The child is between the ages of 3-8,
3. Being admitted due to respiratory system disease,
4. Inhaler treatment with a nebulizer will be applied.
Exclusion Criteria
2. Intravenous, intramuscular or any other treatment request,
3. The child has any genetic, congenital, chronic or metabolic disease,
4. The child has vision, hearing and speech problems,
5. The child's vital signs are unstable (no fever, tachypnea, etc.) and the need for any emergency intervention.
3 Years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayşe Kahraman
associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University
Izmir, Bornova, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.